Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Higgins

Showing results (391-400 of 675) with videos related to

Pageof 68
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 11, 2019
An assay for screening xenobiotics for inhibition of rat thyroid gland peroxidase activityRoger J Price, Rachel Burch, Lynsey R Chatham, et al.
Antiviral Research|August 1, 1983
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2R J Phillpotts, G M Scott, P G Higgins, et al.
Thorax|September 1, 1993
Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sampleB G Higgins, J R Britton, S Chinn, et al.
Calcified Tissue International|December 7, 2007
The association between cysteine, bone turnover, and low bone massM Baines, M-B Kredan, A Davison, et al.
Nucleic Acids Research|September 22, 2017
Mechanistic insight into how multidrug resistant Acinetobacter baumannii response regulator AdeR recognizes an intercistronic regionYurong Wen, Zhenlin Ouyang, Yue Yu, et al.
International Journal of Pediatric Otorhinolaryngology|July 10, 2014
Risk factors for failure of supraglottoplastyC M Douglas, A Shafi, G Higgins, et al.
Medical and Pediatric Oncology|January 1, 1979
Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLLR L Baehner, I D Bernstein, H Sather, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteersA Zerial, G H Werner, R J Phillpotts, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1983
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersP G Higgins, R J Phillpotts, G M Scott, et al.
Cancer Treatment Reports|October 1, 1984
Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study GroupR L Baehner, I D Bernstein, H Sather, et al.
Pageof 68

Showing results (391-400 of 675) with videos related to

Sort By:
Pageof 68
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 11, 2019
An assay for screening xenobiotics for inhibition of rat thyroid gland peroxidase activityRoger J Price, Rachel Burch, Lynsey R Chatham, et al.
Antiviral Research|August 1, 1983
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2R J Phillpotts, G M Scott, P G Higgins, et al.
Thorax|September 1, 1993
Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sampleB G Higgins, J R Britton, S Chinn, et al.
Calcified Tissue International|December 7, 2007
The association between cysteine, bone turnover, and low bone massM Baines, M-B Kredan, A Davison, et al.
Nucleic Acids Research|September 22, 2017
Mechanistic insight into how multidrug resistant Acinetobacter baumannii response regulator AdeR recognizes an intercistronic regionYurong Wen, Zhenlin Ouyang, Yue Yu, et al.
International Journal of Pediatric Otorhinolaryngology|July 10, 2014
Risk factors for failure of supraglottoplastyC M Douglas, A Shafi, G Higgins, et al.
Medical and Pediatric Oncology|January 1, 1979
Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLLR L Baehner, I D Bernstein, H Sather, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteersA Zerial, G H Werner, R J Phillpotts, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1983
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersP G Higgins, R J Phillpotts, G M Scott, et al.
Cancer Treatment Reports|October 1, 1984
Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study GroupR L Baehner, I D Bernstein, H Sather, et al.
Pageof 68